Physician profile
David Christensen
NPI 1922041961
$4,643.91
in general payments reported to CMS, 2019-2025
8 companies · $2,318 in 2025
The $2,318 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,009 · 2020: $601 · 2021: $34.83 · 2022: $538 · 2023: $38.16 · 2024: $105 · 2025: $2,318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,135 · Food and Beverage: $327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,134.51 |
| Food and Beverage | $326.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $4,368.45 | 2019-2025 | Excelsius Gps, Xpand / Xpand-R, Revere 5.5 |
| Shoulder Innovations, INC. | $103.79 | 2025 | Inset System |
| Stryker Corporation | $62.98 | 2025 | Mako |
| Cerapedics INC. | $38.16 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Smith+Nephew, INC. | $28.09 | 2019 | |
| Sawtooth Surgical Solutions INC | $14.55 | 2024 | |
| Boston Scientific Corporation | $14.43 | 2024 | |
| Turn-Key Medical, INC. | $13.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Christensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.